IL142088A0 - Methods and compositions for inhibiting neoplastic cell growth - Google Patents

Methods and compositions for inhibiting neoplastic cell growth

Info

Publication number: IL142088A0
Authority: IL; Israel
Prior art keywords: methods; compositions; cell growth; neoplastic cell; inhibiting neoplastic
Prior art date: 1998-10-13

Application number

IL14208899A

Other languages

English (en)

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-13

Filing date

1999-10-05

Publication date

2002-03-10

1999-10-05 Application filed by Genentech Inc filed Critical Genentech Inc

2002-03-10 Publication of IL142088A0 publication Critical patent/IL142088A0/xx

Links

238000000034 method Methods 0.000 title abstract 4
230000002401 inhibitory effect Effects 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
230000009826 neoplastic cell growth Effects 0.000 title abstract 2
230000000259 anti-tumor effect Effects 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000012010 growth Effects 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IL14208899A 1998-10-13 1999-10-05 Methods and compositions for inhibiting neoplastic cell growth IL142088A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10408098P	1998-10-13	1998-10-13
PCT/US1999/023089 WO2000021996A2 (en)	1998-10-13	1999-10-05	Methods and compositions for inhibiting neoplastic cell growth

Publications (1)

Publication Number	Publication Date
IL142088A0 true IL142088A0 (en)	2002-03-10

Family

ID=22298575

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL14208899A IL142088A0 (en)	1998-10-13	1999-10-05	Methods and compositions for inhibiting neoplastic cell growth
IL142088A IL142088A (en)	1998-10-13	2001-03-19	Use of a pro172 polypeptide in the preparation of pharmaceutical compositions for inhibiting neoplastic cell growth
IL189502A IL189502A0 (en)	1998-10-13	2008-02-13	Methods and compositions for inhibiting neoplastic cell growth

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL142088A IL142088A (en)	1998-10-13	2001-03-19	Use of a pro172 polypeptide in the preparation of pharmaceutical compositions for inhibiting neoplastic cell growth
IL189502A IL189502A0 (en)	1998-10-13	2008-02-13	Methods and compositions for inhibiting neoplastic cell growth

Country Status (15)

Country	Link
EP (1)	EP1121439B1 (de)
JP (1)	JP2002527452A (de)
KR (2)	KR100448426B1 (de)
AT (2)	ATE332970T1 (de)
AU (1)	AU758462B2 (de)
CA (1)	CA2344465A1 (de)
DE (2)	DE69932342T2 (de)
DK (2)	DK1121439T3 (de)
ES (2)	ES2268901T3 (de)
IL (3)	IL142088A0 (de)
MX (1)	MXPA01003636A (de)
NZ (1)	NZ510584A (de)
PT (2)	PT1518930E (de)
WO (1)	WO2000021996A2 (de)
ZA (1)	ZA200102380B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7169906B2 (en)	1997-09-17	2007-01-30	Genentech, Inc.	PRO211 polypeptides
US6974689B1 (en)	1997-09-18	2005-12-13	Genentech, Inc.	Nucleic acid encoding PRO211 polypeptides
CA2406855A1 (en) *	2000-04-21	2001-11-01	Takeda Chemical Industries, Ltd.	Novel insulin/igf/relaxin family polypeptides and dnas thereof
AU2008342942A1 (en) *	2007-12-28	2009-07-09	Biolnvent International Ab	Formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ226799A (en) *	1987-11-06	1991-08-27	Oncogen	Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) *	1989-04-10	1998-09-29	Bristol-Myers Squibb Company	Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) *	1990-04-03	1995-05-16	Bristol-Myers Squibb Company	Epithelins: novel cysteine-rich growth modulating proteins
WO1999014328A2 (en) *	1997-09-17	1999-03-25	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999014327A2 (en) *	1997-09-17	1999-03-25	Genentech, Inc.	Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer

1999
- 1999-10-05 JP JP2000575898A patent/JP2002527452A/ja active Pending
- 1999-10-05 DE DE69932342T patent/DE69932342T2/de not_active Expired - Lifetime
- 1999-10-05 AT AT99970398T patent/ATE332970T1/de active
- 1999-10-05 AT AT04025897T patent/ATE363536T1/de active
- 1999-10-05 PT PT04025897T patent/PT1518930E/pt unknown
- 1999-10-05 ES ES99970398T patent/ES2268901T3/es not_active Expired - Lifetime
- 1999-10-05 DE DE69936234T patent/DE69936234T2/de not_active Expired - Lifetime
- 1999-10-05 WO PCT/US1999/023089 patent/WO2000021996A2/en not_active Ceased
- 1999-10-05 EP EP99970398A patent/EP1121439B1/de not_active Expired - Lifetime
- 1999-10-05 NZ NZ510584A patent/NZ510584A/xx not_active IP Right Cessation
- 1999-10-05 KR KR10-2001-7004627A patent/KR100448426B1/ko not_active Expired - Fee Related
- 1999-10-05 PT PT99970398T patent/PT1121439E/pt unknown
- 1999-10-05 ES ES04025897T patent/ES2290606T3/es not_active Expired - Lifetime
- 1999-10-05 AU AU12005/00A patent/AU758462B2/en not_active Expired
- 1999-10-05 IL IL14208899A patent/IL142088A0/xx active IP Right Grant
- 1999-10-05 DK DK99970398T patent/DK1121439T3/da active
- 1999-10-05 CA CA002344465A patent/CA2344465A1/en not_active Abandoned
- 1999-10-05 DK DK04025897T patent/DK1518930T3/da active
- 1999-10-05 MX MXPA01003636A patent/MXPA01003636A/es active IP Right Grant
- 1999-10-05 KR KR10-2003-7014739A patent/KR100448427B1/ko not_active Expired - Fee Related
- 1999-10-05 ZA ZA200102380A patent/ZA200102380B/en unknown
2001
- 2001-03-19 IL IL142088A patent/IL142088A/en not_active IP Right Cessation
2008
- 2008-02-13 IL IL189502A patent/IL189502A0/en unknown

Also Published As

Publication number	Publication date
KR100448426B1 (ko)	2004-09-13
EP1121439B1 (de)	2006-07-12
ES2290606T3 (es)	2008-02-16
DE69932342T2 (de)	2007-07-12
PT1121439E (pt)	2006-12-29
AU758462B2 (en)	2003-03-20
DE69936234D1 (de)	2007-07-12
KR100448427B1 (ko)	2004-09-16
DK1121439T3 (da)	2006-11-13
IL142088A (en)	2008-11-26
WO2000021996A3 (en)	2000-11-09
KR20010085915A (ko)	2001-09-07
ATE363536T1 (de)	2007-06-15
WO2000021996A2 (en)	2000-04-20
CA2344465A1 (en)	2000-04-20
AU1200500A (en)	2000-05-01
KR20030096387A (ko)	2003-12-24
DK1518930T3 (da)	2007-10-01
ZA200102380B (en)	2002-03-22
PT1518930E (pt)	2007-09-04
DE69936234T2 (de)	2008-03-06
DE69932342D1 (de)	2006-08-24
NZ510584A (en)	2003-04-29
ES2268901T3 (es)	2007-03-16
JP2002527452A (ja)	2002-08-27
MXPA01003636A (es)	2003-10-14
ATE332970T1 (de)	2006-08-15
EP1121439A2 (de)	2001-08-08
IL189502A0 (en)	2008-06-05

Legal Events

Date	Code	Title
2009-09-15	FF	Patent granted
2009-09-15	KB	Patent renewed
2010-04-29	KB	Patent renewed

Publication	Publication Date	Title
AP9901478A0 (en)	1999-03-31	Compounds for the treatment of ischemia.
WO2002080754A3 (en)	2002-12-19	Methods for using annexin for detecting cell death in vivo and treating associated conditions
WO2001075178A3 (en)	2002-06-06	Methods for identifying peptide aptamers capable of altering a cell phenotype
AP2000001919A0 (en)	2000-09-30	Inhibitors of caspases.
BG104392A (en)	2000-12-29	Methods for the modulation of serin/treonin protein kinase function with compounds based on 5-azaquinoxaline
WO2005023824A3 (en)	2005-06-09	Methods for inhibiting tumor cell proliferation
AU9102198A (en)	1998-11-27	Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
NO20012152L (no)	2001-07-05	Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav
IL156584A0 (en)	2004-01-04	Substituted triazole diamine derivatives as kinase inhibitors
IL137229A0 (en)	2001-07-24	Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
IL141513A0 (en)	2002-03-10	Inhibitors of bacterial nad synthetase
AU5892399A (en)	2000-03-21	1, 2, 4-triazole-3-thione compounds
HK1039449A1 (zh)	2002-04-26	治疗多发性硬化的方法
PL335699A1 (en)	2000-05-08	Tetrahydropyridic compounds
IL189502A0 (en)	2008-06-05	Methods and compositions for inhibiting neoplastic cell growth
MX9605072A (es)	1997-08-30	Dispositivo dispensador para pretratamiento.
WO2003024405A3 (en)	2003-12-04	Methods and compositions for inhibiting the proliferation of prostate cancer cells
EP0943620A3 (de)	2001-02-07	Betulinsauer Derivate zur Hemmung von Krebswachstum
AU3896899A (en)	1999-11-29	Compositions for the treatment of tumors, and uses thereof
AU2333999A (en)	1999-08-09	Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
AU2002228913A1 (en)	2002-06-24	Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer
IL139144A0 (en)	2001-11-25	Mycobacterial inhibitors
EP1518930A3 (de)	2005-05-04	Verfahren und Zusammensetzung zur Hemmung des Wachsdums von neoplastischen Zellen
AU2342299A (en)	1999-08-09	Compositions and methods for detecting and treating breast cancer
WO2000012754A8 (en)	2000-08-10	Method for identifying substances for the treatment of c-jun-mediated disorders